BioSpace News Archive

Hepatitis A Vaccine - Rising Health Awareness Among People Due To High Prevalence Of Diseases Is A Major Factor Expected To Positively Impact Market Revenue Growth Going Ahead | Reports and Data

The industry analysis report is considered a valuable source of information about the global Hepatitis A Vaccine industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 25, 2022
·
6 min read
Virtual Clinical Trial Market By Study Design, By Indication, and By Region Forecast To 2028 – Reports and Data

The industry analysis report is considered a valuable source of information about the global Virtual Clinical Trial industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 25, 2022
·
7 min read
Biotech Bay

Bay Area Lyme Foundation Funds $8M in Tick-borne Disease Research During the PandemicFoundation Embraces National Focus on Infectious Diseases as Education Tool

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced that the organization has raised more than $8 million since the beginning of the pandemic of which 100% will be used directly for research and education programs focused on achieving its mission of making Lyme disease easy to diagnose and simple to cure.

January 25, 2022
·
7 min read
Macomics Announces Five Additional Internationally Renowned Advisors with Immuno-oncology and Clinical Expertise

They join Prof. Michele De Palma and Dr Jackie Doody world recognised experts in the fields of immuno-oncology, and Dr John Haurum who has over two decades’ experience in the international biotech industry, most recently as Chief Executive Officer of F-star.

January 25, 2022
·
4 min read
Business

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2021 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2021 financial results conference call and webcast for 5:00 a.m. Pacific Time ( 8:00 a.m. Eastern Time ) on Friday, February 11, 2022.

January 25, 2022
·
1 min read
Biotech Beach

Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent

Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the award of another new patent related to its single-molecule detection assay platform under development.

January 25, 2022
·
4 min read
Biotech Beach

IMX-110 + anti-PD-1 Combination Produced Extended Median Survival in Genetic Pancreatic Cancer Mouse Model, Bolstering Planned 2022 IMX-110 Combination Clinical Trial Rationale

Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”), today announced data showing that IMX-110 + anti-PD-1 produced 63-day median survival in a genetic pancreatic cancer mouse model in which mice develop their own pancreatic cancer and have an intact immune system.

January 25, 2022
·
5 min read
BioMidwest

200th Treatment Milestone for AIRFLOW-3 COPD Trial

Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment milestones.

January 25, 2022
·
3 min read
BioForest

Predicting Long COVID at Initial Point of COVID-19 Diagnosis: Institute for Systems Biology-Led Study Finds Several Warning Factors

A significant portion of people who contract the SARS-CoV-2 virus – some estimates suggest more than 40 percent – suffer chronic effects known as Post Acute Sequelae of COVID-19 (PASC), commonly referred to as long COVID.

January 25, 2022
·
4 min read
Pharm Country

Halberd CEO Letter: 2021 Year-End & 2022 Outlook

Greetings From The CEO And Staff At HALBERD CORPORATION (OTC Pink: HALB)!

January 25, 2022
·
8 min read